A coordination unit for clinical trials in Belgium

Most clinical trials [1] are coordinated at a European level in paediatric oncology; however, each participating country must have the clinical trial approved at its own national level and for so-called "academic" trials (which are not funded by a pharmaceutical company), seek its own funding.

The Belgian Paediatric Oncology Association (BSPHO [2]) currently does not have enough internal ressources to sustainably support its efforts to participate in all European clinical trials. KickCancer is committed to allocating the first € 100.000 raised each year during the RUN TO KICK race to finance the first stones of this coordination cell.

The aim of this cell is to enable the Belgian centres to coordinate their research activities in order to make them more effective and improve the care provided to Belgian patients.

First steps: In conjunction with the King Baudouin Foundation, KickCancer will provide the BSPHO with necessary resources to enable physicians to prepare their clinical trial files without encroaching on their clinical or research time.

Long-term development: In the longer run, KickCancer wants to convince other Belgian institutions to finance this coordination cell. The expansion will provide Belgian paediatric oncology centres with a structural and coordinated support for setting up and funding their clinical trials. The underlying vision, naturally, is to improve the therapeutic offer in Belgium for children with cancer.

[1] Al those organized in Belgium – only big countries such as France, Germany, etc. have sufficient own recruitment capacity to organize a clinical trial at a purely national level.

[2] Belgian Association for Pediatric Haemato-Oncology

Objectives

100%
Objective: 100 000 euros per year
More than 95% of your donations go to financing research and supporting our advocacy work, less than 5% go to administration.
Donate

Our other projects

Liquid biopsies

For children with rhabdomyosarcoma, assessing response to treatment and whether they remain in remission requires regular imaging such as MRI. In some types of cancer, but not rhabdomyosarcoma, it has been shown to be clinically useful to assess abnormal DNA released from a cancer into the blood stream.

View the project
91%
150 000 over 1 year
Donate

A better cure for an incurable brain tumour

Brain tumours are the main causes of mortality and morbidity of children, adolescents and young adults. Gliomas are the most frequent and the most fatal kind, among which the diffuse intrinsic pontic gliomas (or DIPG) represents the most severe form, universally incurable with hardly any patients surviving more than 2 years after the diagnosis.

View the project
100%
150 000 over 1 year
Donate

European call for research projects

Today research is often funded at a national level or through research networks. When charities fundraise, they are looking for projects on their own and have them reviewed either by an inhouse scientific committee or through an ad hoc peer review process. Some greater calls for projects are organised, but then, again, they are often aimed at national projects.

View the project
90%
600 000 euros at the end of 2019
Donate